Rotech Bondholders Want Baker & McKenzie Fees Capped

Law360, New York (May 15, 2013, 4:44 PM EDT) -- Rotech Healthcare Inc.’s bondholders on Wednesday echoed the bankrupt medical equipment maker’s opposition to the retention of Baker & McKenzie LLP on an hourly basis as counsel for the official equity committee, saying the firm should only be compensated by a contingent fee.

Capital Research and Management Co., Fidelity Investments, Silver Point Capital LP and Venor Capital Management LP, as holders of approximately $290 million in second lien notes, said until creditors are paid in full, counsel for the equity committee should either work on a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.